European Heart Journal Advance Access published online on January 24, 2006
European Heart Journal, doi:10.1093/eurheartj/ehi747
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Medical Clinic I, University Hospital, RWTH Aachen University, Pauwelsstrasse 30, Aachen 52057, Germany; Interdisciplinary Center for Clinical Research on Biomaterials and Tissue-Material-Interaction in Implants (IZKF Biomat), University Hospital, RWTH Aachen University, Pauwelsstrasse 30, Aachen 52057, Germany
* To whom correspondence should be addressed. Aims The aim of the study was to compare, in patients with chronic ischaemic cardiomyopathy, contrast-enhanced cardiovascular magnetic resonance (ce-CMR) imaging and a combined 18F-fluorodeoxyglucose (18F-FDG) positron emission tomography (PET) and 99mTc-sestamibi single-photon emission computed tomography (SPECT) protocols for the prediction of functional recovery after revascularization, as assessed by cine CMR. Methods and results Twenty-nine patients with ischaemic cardiomyopathy (ejection fraction 32 ± 10%) were investigated with ce-CMR and PET/SPECT. For the assessment of global and regional functions, cine CMR was performed at baseline and at 6 months follow-up. For ce-CMR, the segmental extent of hyperenhancement (SEH) was quantitated, and for PET/SPECT, different viability categories were defined according to a validated quantitative protocol. Functional improvement was related to the SEH by ce-CMR, as well as to the viability categories by PET/SPECT. Sensitivity and specificity for the prediction of functional recovery at follow-up was 97 and 68% for ce-CMR and 87 and 76% for PET/SPECT. The positive predictive value was identical for both techniques (73%). However, ce-CMR achieved a higher negative predictive value (93 vs. 77%, respectively), indicating that ce-CMR may be superior to PET/SPECT for the identification of segments unlikely to recover function after revascularization. Both methods had a similar yield in the prediction of global functional improvement. Conclusion ce-CMR is comparable with a PET/SPECT imaging protocol for the prediction of regional and global functional improvement after revascularization. However, ce-CMR may be superior to nuclear imaging for the identification of segments that are unlikely to recover function at follow-up.
Received June 20, 2005
Revised January 3, 2006
Accepted January 5, 2006
Clinical research
Assessment of reversible myocardial dysfunction in chronic ischaemic heart disease: comparison of contrast-enhanced cardiovascular magnetic resonance and a combined positron emission tomography-single photon emission computed tomography imaging protocol
Harald P. Kühl 1 *,
Claudia S.A. Lipke 1,
Gabriele A. Krombach 2,
Marcus Katoh 2,
Thomas F. Battenberg 3,
Bernd Nowak 4,
Nicole Heussen 5,
Arno Buecker 2,
and
Wolfgang M. Schaefer 6
2 Department of Diagnostic Radiology, University Hospital, RWTH Aachen University, Pauwelsstrasse 30, Aachen 52057, Germany
3 Medical Clinic I, University Hospital, RWTH Aachen University, Pauwelsstrasse 30, Aachen 52057, Germany
4 Department of Nuclear Medicine, University Hospital, RWTH Aachen University, Pauwelsstrasse 30, Aachen 52057, Germany
5 Department of Medical Statistics, University Hospital, RWTH Aachen University, Pauwelsstrasse 30, Aachen 52057, Germany
6 Interdisciplinary Center for Clinical Research on Biomaterials and Tissue-Material-Interaction in Implants (IZKF Biomat), University Hospital, RWTH Aachen University, Pauwelsstrasse 30, Aachen 52057, Germany; Department of Nuclear Medicine, University Hospital, RWTH Aachen University, Pauwelsstrasse 30, Aachen 52057, Germany
Harald P. Kühl, E-mail: hkuehl{at}ukaachen.de
![]()
Abstract ![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
T. Mihaljevic, A. M. Gillinov, and J. F. Sabik III Functional Ischemic Mitral Regurgitation: Myocardial Viability as a Predictor of Postoperative Outcome After Isolated Coronary Artery Bypass Grafting Circulation, October 13, 2009; 120(15): 1459 - 1461. [Full Text] [PDF] |
||||
![]() |
G. A. Beller and L. P. Budge Viable: Yes, No, or Somewhere in the Middle? J. Am. Coll. Cardiol. Img., September 1, 2009; 2(9): 1069 - 1071. [Full Text] [PDF] |
||||
![]() |
F Alpendurada, J Wong, and D J Pennell Practical applications of cardiovascular magnetic resonance Heart Asia, March 31, 2009; 2009(3): 16 - 22. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Neizel, D. Lossnitzer, G. Korosoglou, T. Schaufele, H. Peykarjou, H. Steen, C. Ocklenburg, E. Giannitsis, H. A. Katus, and N. F. Osman Strain-Encoded MRI for Evaluation of Left Ventricular Function and Transmurality in Acute Myocardial Infarction Circ Cardiovasc Imaging, March 1, 2009; 2(2): 116 - 122. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Becker, A. Lenzen, C. Ocklenburg, K. Stempel, H. Kuhl, M. Neizel, M. Katoh, R. Kramann, J. Wildberger, M. Kelm, et al. Myocardial Deformation Imaging Based on Ultrasonic Pixel Tracking to Identify Reversible Myocardial Dysfunction J. Am. Coll. Cardiol., April 15, 2008; 51(15): 1473 - 1481. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. G. Camici, S. K. Prasad, and O. E. Rimoldi Stunning, Hibernation, and Assessment of Myocardial Viability Circulation, January 1, 2008; 117(1): 103 - 114. [Full Text] [PDF] |
||||
![]() |
Y.-W. Wu, E. Tadamura, M. Yamamuro, S. Kanao, A. Marui, K. Tanabara, M. Komeda, and K. Togashi Comparison of Contrast-Enhanced MRI with 18F-FDG PET/201Tl SPECT in Dysfunctional Myocardium: Relation to Early Functional Outcome After Surgical Revascularization in Chronic Ischemic Heart Disease J. Nucl. Med., July 1, 2007; 48(7): 1096 - 1103. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. Gibbons, P. A. Araoz, and E. E. Williamson The Year in Cardiac Imaging J. Am. Coll. Cardiol., December 5, 2006; 48(11): 2324 - 2339. [Full Text] [PDF] |
||||





